How big is the Gene Therapy Platform market?

The global gene therapy platform market size was valued at USD 2.14 billion in 2024 and is expected to reach USD 2.43 billion in 2025.

What is the Gene Therapy Platform market growth?

The global gene therapy platform market is expected to grow at a compound annual growth rate of 15.22% from 2025 to 2030 to reach USD 4.93 billion by 2030.

Which segment accounted for the largest Gene Therapy Platform market share?

The North America region dominated the market in 2024 with a revenue share of 35.96%. The region continues to dominate global gene therapy advancements, with a flourishing biotech ecosystem driving the development of advanced technologies such as viral vectors and CRISPR gene editing.

Who are the key players in Gene Therapy Platform market?

Some key players operating in the Healthcare gamification market are Lonza, BioIT, Autolomous Ltd, Hypertrust Patient Data Care (Part of Accenture), IBM, L7 Informatics, Inc., TrakCel, IDBS, Novartis, SAP SE, DEEP GENOMICS, ElevateBio, Sarepta Therapeutics, Inc., CRISPR Therapeutics, Precision BioSciences, AstraZeneca, Andelyn Biosciences, Renova Therapeutics

What are the factors driving the Gene Therapy Platform market?

The growth is driven by several key drivers, including rapid technological advancements, increasing prevalence of genetic and chronic diseases, growing investments and funding in biopharmaceutical research, and supportive regulatory frameworks facilitating faster approvals. Innovations in viral vector technologies, gene editing tools including CRISPR, and integration of AI and automation in manufacturing are enhancing therapy precision and production efficiency.